Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer

NCT04114825 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer Recurrent

Interventions

BIOLOGICAL: RV001V
OTHER: Placebo

Sponsor

RhoVac APS